SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-085841
Filing Date
2024-10-07
Accepted
2024-10-07 13:56:44
Documents
13
Period of Report
2024-10-07
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea021696801-8k_bioessence.htm   iXBRL 8-K 23478
  Complete submission text file 0001213900-24-085841.txt   190513

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE biocom-20241007.xsd EX-101.SCH 3006
3 XBRL LABEL FILE biocom-20241007_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE biocom-20241007_pre.xml EX-101.PRE 22351
15 EXTRACTED XBRL INSTANCE DOCUMENT ea021696801-8k_bioessence_htm.xml XML 3337
Mailing Address 12 CHRYSLER UNIT B IRVINE CA 92618
Business Address 12 CHRYSLER UNIT B IRVINE CA 92618 949-706-9966
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

IRS No.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56263 | Film No.: 241357189
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)